newsfilter
← Latest News
GlobeNewswire·

Brickell Biotech Reports Second Quarter 2021 Financial Results and Provides Corporate Update

Final patient has completed the Phase 3 pivotal Cardigan I study; Enrollment completed in Phase 3 pivotal Cardigan II study- - -Topline results for Phase 3 pivotal Cardigan I and Cardigan II studies expected to be reported in Q4 2021- - -Recent $8.1 mill